️ Uzbekistan aims to increase the share of domestic pharmaceuticals on its internal market to 70% by 2030 and plans to boost product export volume to $1 billion within the next five years. These targets were outlined during a video conference chaired by President Shavkat Mirziyoyev, focusing on priority tasks for the development of the pharmaceutical sector. The head of state emphasized that this field serves as a foundation not only for public health and quality of life but also for the country's overall economic security.
️ Large-scale reforms in medicine and enhanced preventive care at the primary level require a multiple-fold increase in the production of modern drugs. In this context, responsible officials have been tasked with attracting at least $1 billion in investments into the industry this year alone. These funds will be directed toward creating new capacities in partnership with leading global pharmaceutical companies, which is expected to significantly expand the range of localized products.
️ The basis for this leap forward has been laid by the results of the past nine years, during which $1.8 billion was invested into the sector. Over this period, 140 new production facilities were launched in the republic, and the total number of specialized enterprises exceeded 300. Thanks to the conditions created, production volume grew 3.5 times, reaching 7.3 trillion soums, while export geography expanded to 55 countries. Currently, the combined market for medicines and medical devices in Uzbekistan is estimated at nearly $2.5 billion.
️ Despite the achieved indicators, the meeting highlighted the need for closer interaction between authorities and businesses. Specifically, the president pointed out the lack of a systematic approach among regional leaders in addressing the problems of local producers.
️ To rectify the situation, a draft large-scale resolution has already been prepared based on proposals from over 400 market participants—manufacturers, importers, and trading companies. The document aims to eliminate administrative barriers and create conditions for healthy competition, which will ultimately make quality medicines more accessible to citizens.
️ Previously, it was reported that the international pharmaceutical company STADA sees strategic prospects in the Uzbek market and hopes that in the coming years, the country could surpass Kazakhstan in terms of pharmaceutical development level.
Source: podrobno.uz